| Prev Close | 18.85 |
| Open | 18.50 |
| Day Low/High | 16.72 / 18.50 |
| 52 Wk Low/High | 3.58 / 20.96 |
| Volume | 3.83M |
Dynavax Technologies Corporation (DVAX)
18.12
0.73
3.87
NASDAQ
| Exchange | NASDAQ |
| Shares Outstanding | 114.76B |
| Market Cap | 2.16B |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Latest News
Dismiss the Impact of Rising Inflation and COVID Cases at Your Own Risk
The overall market seems to be mispricing the threats of rapidly increasing prices and the fast-spreading Delta variant.
There's Good News for 3 Biotech Names
And It comes after one of the best days of the year for the biotech sector.
Taiwan Administers First Home-Made Vaccine
Watch Medigen stock, as the Taiwanese president becomes one of the first citizens of the island nation to roll up her sleeve.
Here's What to Do When You Don't Have Strong Conviction in the Markets
Sometimes it's best to move to the sidelines until something changes.
2 Biotech Stocks to Watch
Dynavax Technologies and Albireo Pharma are names for consideration while investors wait for sentiment on the biotech sector to eventually turn around.
It's Time for Bargain Shopping in the Biotech Aisle
Dynavax Technologies, Kala Pharmaceuticals and TherapeuticsMD are three names this biotech investor plans to add exposure to via covered calls.
Biotech Isn't Seeing Much Merger Activity, but Here's a Stock to Like
Dynavax Technologies has inked a supply deal related to a Covid-19 vaccine that could greatly increase its revenue stream.
2 Small Biotechs Face Crossroads Years in 2020
Dynavax Technologies and Omeros Corp. have tested shareholders' patience over time and again are at inflection points.
A Trio of Small Biotech Companies Garnering Attention
The three either have made recent progress toward advancing products in their pipelines or have caught the eye of analysts.
2 Small Biotechs With Sagging Shares but Promising Prospects
The stocks of these two developmental concerns have slid recently, but there are reasons to believe they will improve.
Hopeful Signs for These 2 Small Biotech Stocks
Few parts of this biotech space are more frustrating that what I have dubbed 'Tier 3' biotech concerns.
3 Biotech Stocks Boasting Earnings Beats - and Healthy Outlooks
Quick takes on fourth-quarter results from these 3 biotech names.
2 Small-Caps That Should Continue to Stage Comebacks in 2019
Beaten-down Entercom Communications and Dynavax Technologies are off to good starts this year and should continue to improve.
Buy Struggling Progenics and Dynavax Here
Both biotech stocks are at or near 52-week lows, but don't deserve to be.
Seeking Bargains on Last Week's Selloff
These 5 stocks are a good value on this weakness.
3 Small Biotechs Turn on the Revenue Jets
BioDelivery Sciences, Neos Therapeutics and Invitae Corp. are delivering big increases in sales.
Biotech Bargains: Two Cheap Small-Cap Stocks in an Exciting Sector
I continue to see these names as bargains in the biotech and biopharma space.
Small Cap Biotech Bargains
Here are 2 small caps I continue to see as bargains in this space.
4 Names to Watch Ahead of This Year's Key Cancer-Research Conference
These names are moving up or down in a big way ahead of releasing drug-trial results.
4 Names to Watch Ahead of Cancer Conference
American Society of Clinical Oncology will see presentations from dozens of companies.
4 Names to Buy in a Refreshed Biotech Space
After a strong week for the biotech sector, these names have potential catalysts to move shares.
Watch Oncology Stocks Ahead of 2 Big Events
Data and industry conferences will likely be catalysts for shares in the space.
3 Favorite Biotech Stocks for the Second Quarter
Your questions are answered in our latest addition of the biotech mailbag.
Watch These Biotechs and the FDA Calendar
Here are a few key events I will be watching closely for in the months ahead on stocks I think are buys at current levels.
3 Key Biotech Catalysts on the FDA Calendar
A roundup of biotech names with actions pending at the FDA in coming weeks.
5 Small Biotechs Receive Shots in the Arm
Favorable quarterly results and FDA drug approvals should help lift these five names.
5 Small Biotechs Receive Shots in the Arm
Favorable quarterly results and FDA drug approvals should help lift these five names.
Acadia, Dynavax Make the Biotech Mailbag
Readers have asked about Acadia Pharmaceuticals and Dynavax Technologies, so we answer.
